Get the Stockscreener App
6.78
6.61%
-0.48
After Hours:
6.55
-0.23
-3.39%
Rxsight Inc stock is traded at $6.78, with a volume of 1.40M.
It is down -6.61% in the last 24 hours and down -3.42% over the past month.
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.
See More
Previous Close:
$7.26
Open:
$7.26
24h Volume:
1.40M
Relative Volume:
1.76
Market Cap:
$280.67M
Revenue:
$134.48M
Net Income/Loss:
$-38.94M
P/E Ratio:
-7.1114
EPS:
-0.9534
Net Cash Flow:
$-19.34M
1W Performance:
-0.44%
1M Performance:
-3.42%
6M Performance:
-21.25%
1Y Performance:
-51.40%
1-Day Range:
$6.75
$7.26
1-Week Range:
$6.75
$7.49
52-Week Range:
$5.90
$16.74
Rxsight Inc Stock (RXST) Company Profile
Name
Rxsight Inc
Sector
Industry
Phone
949-521-7822
Address
100 COLUMBIA STREET, ALISO VIEJO
Compare RXST vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
6.78 | 300.54M | 134.48M | -38.94M | -19.34M | -0.9534 |
ABT
Abbott Laboratories
|
86.30 | 151.83B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
292.33 | 113.08B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.60 | 99.87B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
56.00 | 83.21B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.20 | 47.80B | 6.30B | 1.07B | 1.34B | 1.8406 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-26 | Initiated | William Blair | Mkt Perform |
| Jul-15-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-10-25 | Downgrade | Jefferies | Buy → Hold |
| Jul-09-25 | Downgrade | BTIG Research | Buy → Neutral |
| Jul-09-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-09-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-19-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-15-25 | Initiated | Piper Sandler | Neutral |
| Apr-09-25 | Downgrade | UBS | Buy → Neutral |
| Apr-04-25 | Downgrade | JP Morgan | Overweight → Underweight |
| Apr-03-25 | Downgrade | BofA Securities | Buy → Underperform |
| Dec-20-24 | Downgrade | Stifel | Buy → Hold |
| Dec-11-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-06-24 | Initiated | UBS | Buy |
| Oct-29-24 | Initiated | Jefferies | Buy |
| Aug-20-24 | Reiterated | Needham | Buy |
| Aug-06-24 | Reiterated | Needham | Buy |
| May-07-24 | Reiterated | BTIG Research | Buy |
| Dec-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Initiated | Morgan Stanley | Overweight |
| Apr-13-23 | Initiated | Oppenheimer | Outperform |
| Dec-12-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-08-22 | Initiated | Needham | Buy |
View All
Rxsight Inc Stock (RXST) Latest News
Rxsight Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
Behavioral Patterns of RXST and Institutional Flows - Stock Traders Daily
How The RxSight (RXST) Narrative Is Shifting After 2026 Guidance And Target Resets - Yahoo! Finance Canada
RxSight, Inc. to Present at the Bank of America Healthcare Conference - Bluefield Daily Telegraph
Needham Maintains RxSight (RXST) Buy Recommendation - MSN
RxSight (RXST) to Release Earnings on Wednesday - MarketBeat
RxSight (NASDAQ: RXST) sets 2026 virtual meeting on directors, pay and auditor - Stock Titan
[ARS] RxSight, Inc. SEC Filing - Stock Titan
(RXST) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6 - The Manila Times
RXST SEC FilingsRxsight, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
RxSight (RXST) COO exercises stock options, now holding over 79,000 shares - Stock Titan
How The RxSight (RXST) Story Is Shifting With New Guidance And Street Price Targets - Yahoo Finance
RxSight (RXST) Stock: Mid-Year Review (Extends Gains) 2026-04-18Volatility Analysis - Cổng thông tin điện tử tỉnh Lào Cai
RxSight, Inc. (RXST) Stock Analysis: Exploring a 34% Potential Upside Amidst Market Challenges - DirectorsTalk Interviews
Analysts’ Top Healthcare Picks: RxSight (RXST), Ultragenyx Pharmaceutical (RARE) - The Globe and Mail
Needham Maintains RxSight(RXST.US) With Buy Rating, Maintains Target Price $13 - Moomoo
RXST: Premium lens adoption grows as utilization deepens and international expansion accelerates - TradingView
RxSight (RXST) Stock: Valuation Analysis (Steady Decline) 2026-04-15Scalping - Cổng thông tin điện tử tỉnh Lào Cai
Volume Summary: Will RxSight Inc benefit from geopolitical trends2026 Short Interest & Weekly Top Stock Performers List - baoquankhu1.vn
Trend Report: Is RxSight Inc forming a double bottom2026 Key Lessons & Stepwise Trade Signal Guides - baoquankhu1.vn
Retail Surge: Can RxSight Inc deliver consistent EPS growthWeekly Trend Summary & Fast Exit Strategy with Risk Control - baoquankhu1.vn
How (RXST) Movements Inform Risk Allocation Models - Stock Traders Daily
RxSight, Inc. (NASDAQ:RXST) Given Consensus Recommendation of "Reduce" by Analysts - MarketBeat
Gains Report: What is RxSight Incs valuation compared to sector2026 Intraday Action & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Market Moves: Will RxSight Inc stock hit new highs in YEARQuarterly Earnings Report & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Analysis Recap: Will RxSight Inc benefit from geopolitical trendsJobs Report & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Investment Recap: Will RxSight Inc benefit from geopolitical trendsSwing Trade & Stepwise Trade Signal Guides - baoquankhu1.vn
RxSight Inc stock: 300,000 Lens Milestone Signals Growth Potential - AD HOC NEWS
RxSight Reaches 300,000 Light Adjustable Lens Implant Milestone - National Today
RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026 - Sahm
RxSight, Inc. (RXST) stock price, news, quote and history - Yahoo Finance Australia
RxSight reports 300,000 Light Adjustable Lens implants milestone By Investing.com - Investing.com South Africa
RxSight reports 300,000 Light Adjustable Lens implants milestone - Investing.com
RxSight reaches 300,000 Light Adjustable Lens implants since launch - StreetInsider
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Shareholders to Reach Out - ACCESS Newswire
RxSight (NASDAQ:RXST) Trading Down 3.7%Time to Sell? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
2026-04-05 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Shareholders to Learn More About the Investigation | NDAQ:RXST | Press Release - Stockhouse
How The Story Is Shifting For RxSight (RXST) On Guidance Leadership And Valuation - Yahoo Finance
RXST PE Ratio & Valuation, Is RXST Overvalued - Intellectia AI
RxSight, Inc. (RXST) Stock Price, News, Quote & History - Yahoo! Finance Canada
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
RxSight to Participate in Annual Healthcare Conference - National Today
RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference - The Manila Times
Earnings Risk: Will RxSight Inc stock hit new highs in YEAR2026 Year in Review & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
RXST Should I Buy - Intellectia AI
Trading Systems Reacting to (RXST) Volatility - Stock Traders Daily
Rxsight Inc Stock (RXST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):